Monday, 8 Jun 2026
Home
Stock Market
Product / Services
Press Releases
Company Announcement
Partnerships
Featured Article
Announces
Crypto
Price
News
Pepeto
Prediction
Market
Launches
Search
Home
Stock Market
Product / Services
Press Releases
Company Announcement
Partnerships
Featured Article
Follow US
Uncontrolled
Partnerships
April 23, 2026
Dupixent® (dupilumab) Authorized within the U.S. because the First Biologic Drugs for Younger Youngsters with Uncontrolled Persistent Spontaneous Urticaria (CSU)